DYN - CIK 0001818794
Dyne Therapeutics, Inc. has filed 710 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (299 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-04-22 | - |
| Insider sale notice | 144 | 2026-04-22 | - |
| Insider trade | 4 | 2026-04-22 | 2026-04-20 |
| Insider sale notice | 144 | 2026-04-21 | - |
| Insider sale notice | 144 | 2026-04-21 | - |
| Insider sale notice | 144 | 2026-04-21 | - |
| Insider sale notice | 144 | 2026-04-21 | - |
| Insider trade | 4 | 2026-04-21 | 2026-04-17 |
| Insider sale notice | 144 | 2026-04-20 | - |
| Insider sale notice | 144 | 2026-04-20 | - |
| Insider sale notice | 144 | 2026-04-20 | - |
| Insider sale notice | 144 | 2026-04-20 | - |
| Insider trade | 4 | 2026-04-17 | 2026-04-15 |
| PRE 14A | - | 2026-04-09 | 2026-04-09 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider sale notice | 144 | 2026-04-01 | - |
| Insider trade | 4 | 2026-04-01 | 2026-03-30 |
| Employee stock plan | S-8 | 2026-03-27 | - |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Insider trade | 4 | 2026-03-13 | 2026-03-11 |
| Insider trade | 4 | 2026-03-13 | 2026-03-11 |
| Insider sale notice | 144 | 2026-03-11 | - |
| Insider trade | 4 | 2026-03-11 | 2026-03-09 |
| Insider trade | 4 | 2026-03-10 | 2026-03-06 |
| Insider sale notice | 144 | 2026-03-09 | - |
| SCHEDULE 13G/A | - | 2026-03-06 | - |
| Insider trade | 4 | 2026-03-06 | 2026-03-05 |
| Insider trade | 4 | 2026-03-06 | 2026-03-05 |
| Insider trade | 4 | 2026-03-06 | 2026-03-05 |
| Insider sale notice | 144 | 2026-03-05 | - |
| Employee stock plan | S-8 | 2026-03-02 | - |
| Major company event | 8-K | 2026-03-02 | 2026-03-02 |
| Annual report | 10-K | 2026-03-02 | 2025-12-31 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-17 | 2026-02-12 |
| Insider trade | 4 | 2026-02-17 | 2026-02-12 |
| Insider trade | 4 | 2026-02-17 | 2026-02-12 |
| Insider trade | 4 | 2026-02-17 | 2026-02-12 |
| Major company event | 8-K | 2026-01-12 | 2026-01-12 |
| SCHEDULE 13G | - | 2026-01-08 | - |
| Insider trade | 4 | 2025-12-23 | 2025-12-22 |
| New insider ownership | 3 | 2025-12-23 | 2025-12-22 |
| Major company event | 8-K | 2025-12-23 | 2025-12-22 |
| Prospectus supplement | 424B5 | 2025-12-10 | - |
| Major company event | 8-K | 2025-12-10 | 2025-12-09 |
| Prospectus supplement | 424B5 | 2025-12-08 | - |
| Major company event | 8-K | 2025-12-08 | 2025-12-08 |
| Major company event | 8-K | 2025-12-08 | 2025-12-08 |
| Insider sale notice | 144 | 2025-12-05 | - |
| Insider sale notice | 144 | 2025-12-05 | - |